Deals
Deals dated after 30 September 2026 are still being collected.
Columns
1 of 1 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2026 | Agomab Therapeutics NV | – | – | IPO | Bookrunner | Announced | 200.0 | Biotech+2 | J.P. Morgan (lead manager)Morgan Stanley (lead manager)Leerink Partners (lead manager)Goodwin (issuer)Baker McKenzie (issuer)Davis Polk (lead manager)Clifford Chance (lead manager) | Agomab Therapeutics NV IPO |